Geoff Whitehead

Geoff Whitehead joined Flagship Ventures in 2008 as a Senior Associate.

Prior to Flagship， Geoff was with PRTM， a worldwide operational strategy management consultancy， most recently as a Manager in their Life Sciences group. At PRTM， Geoff helped create and lead the molecular diagnostics team and managed multiple strategic and operational engagements with leading pharmaceutical， biotechnology， and diagnostics companies. Previously， Geoff worked at Myriad Genetics， where he performed research on identifying drugable targets， enhanced DNA sequencing capabilities and performed human genetics analyses for obesity and diabetes.

Geoff holds a PhD in Genetics from the Biological & Biomedical Sciences program at Harvard Medical School and a BS in Biochemistry from the University of Utah. His PhD research was done in the laboratory of Professor Mark Keating at Children’s Hospital Boston in the fields of regenerative medicine， genetics and developmental biology. His PhD research， showing fgf20a to be required for initiation of fin regeneration in zebrafish， was published in the journal Science.